Objective: Human leukocyte antigen DQ (HLA-DQ) genetic factors and islet autoantibodies are strongly associated with type 1 diabetes (T1D) and are currently used to predict T1D. This study examined whether islet autoantibodies in the cord blood of newborns to nondiabetic mothers were associated with the (T1D) high-risk genotype HLA-DQ2/8, gestational infections or both.
Introduction
Clinical onset of type 1 diabetes (T1D) is the result of an autoimmune destruction of pancreatic islet b-cells. 1 The autoimmune destruction may be observed several years before diagnosis as it is marked by islet autoantibodies (Abs) against glutamic acid decarboxylase (GAD65Ab), islet-associated antigen 2 (IA-2Ab) or insulin autoantibodies (IAA). 2, 3 Number of islet Abs has been shown to predict the clinical onset of T1D, 4, 5 and close to 90% of newly diagnosed T1D patients have GAD65Ab, IA-2Ab or IAA alone, or in combination. 6 Prodromal islet autoimmunity has been established by prospective analyses of newborn children with increased genetic risk for T1D, [7] [8] [9] including children born to parents with T1D. 10 The genetic risk includes a strong association 6 as well as linkage 11 to the human leukocyte antigen DQ (HLA-DQ) locus on chromosome 6. There are two HLA-DQ haplotypes, HLA-DQA1*0301-B1*0302 (DQ8) and HLA-DQA1*0501-B1*0201 (DQ2), which are found in nearly 90% of newly diagnosed T1D children, 6, 12 and the genotype HLA-DQ2/8 confers the highest risk. It has been estimated that HLA-DQ represents about 60% of the familial risk for T1D. Other non-HLA genetic factors also confer risk; however, their overall contribution is superseded by HLA. 11 A large number of epidemiological studies have implicated several nongenetic etiological factors. 13 Infectious agents may be important, as less than 15% of newly diagnosed T1D children have a first-degree relative with the disease 14 and the concordance rate among identical twins is less than 50%. 15 Infections by virus such as coxsackie, echo, rota and mumps are suggested as possible triggers of islet autoimmunity and T1D. 16 The possible role of infections as an early trigger may in part contribute to the increased incidence of T1D among younger children. 17, 18 Early environmental risk factors may therefore play an important role in the triggering or acceleration of T1D. The earliest risk factors reported to be associated with T1D have included gestational infections, [19] [20] [21] ABO incompatibility, 22 parity 23 and factors related to socioeconomic status such as maternal age [24] [25] [26] and birth weight. 27 We recently reported that children who developed T1D younger than 15 years of age show an increased frequency of islet Abs in the cord blood. 28 A prenatal or perinatal effect however may fade over time as patients developing T1D after 15 years of age do not show a similar increase. 29 The risk for T1D after being born with cord blood islet Abs may depend on whether the mother has T1D or not. Children born to T1D mothers with GAD65Ab and IA-2Ab at birth showed a reduced risk for developing multiple islet Abs and T1D as compared to those who were islet Ab negative at birth. 30 It can therefore not be excluded that gestational islet autoimmunity could affect immune tolerance induction in the offspring.
The prevalence of newborns with cord blood Abs is approximately 2 to 3% with a much higher percent when born to T1D mothers. However, after 1 year all children had undetectable levels. It has been speculated that the presence of islet Abs during pregnancy in nondiabetic mothers may reflect subclinical islet autoimmunity which would not only put the mother 31 at increased postnatal risk for T1D but also the offspring. 28 As part of the Diabetes Prediction in Skåne (DiPiS) project, 32 our aim is to identify nongenetic factors that improve positive prediction of T1D. In this study, we hypothesize that the presence of cord blood Abs in children born to nondiabetic mothers are related to both HLA and gestational infections and may mark an altered risk for development of T1D. We have therefore tested whether cord blood islet Abs in the newborn are associated with T1D high-risk HLA-DQ2/8 and history of self-reported-related infections.
Methods

Population
Between September 2000 and August 2004, approximately 75% of all mothers in Skåne participated in DiPiS by agreeing to submit blood samples both from them and the umbilical cord of their offspring. 33 Dried blood spots (DBS) on filters accompanied a registration form as described elsewhere, 34 and when the child was 2 months of age the parents were asked to fill out a questionnaire. In the questionnaire, the mother was asked the following questions, (English translation): 'Did you have any infections during pregnancy (yes or no)? Was there any infection with a fever over 38 1C (in 1st to 3rd month of pregnancy, in 4th to 6th month of pregnancy or in 7th to 9th month of pregnancy)? Was there throwing up and diarrhea in connection with an infection (in 1st to 3rd month of pregnancy, in 4th to 6th month of pregnancy or in 7th to 9th month of pregnancy)?
The study was approved by the Lund University Ethics Committee.
HLA-genotyping
HLA was analyzed on DBS on filters as described elsewhere. 34 HLA-DQ genotypes were available in 32 775 (97.3%) newborns. HLA-DQ2/8 was considered of high risk for both mother and child.
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GAD65 and IA-2 autoantibodies Autoantibodies to GAD65 35 or IA-2 36 were determined in a first combined screen, where eluates from DBS were incubated with labeled antigen, antibody-bound-labeled antigen separated from free-labeled antigen by Sepharose-Protein A (Amersham Biosciences, Uppsala, Sweden) and the radioactivity counted in a Beta Plate Reader (PerkinElmer Life Sciences, Stockholm, Sweden) as described. 34 The combined screen referred as COMB compared a positive reference with two negative reference samples to determine high levels that would require the sample to be analyzed for both GAD65Ab and IA-2Ab in separate assays. The GAD65Ab and IA-2Ab assays showed mean inter-assay coefficients of variation of 14% and intra-assays of 8%.
As potential high (above normal) binding levels of GAD65Ab and IA-2Ab (Figure 1a ), samples greater than the 99th percentile of COMB were individually analyzed for each Ab.
As controls, samples between the 98th and 99th percentile as well as approximately 1000 samples below the 98th percentiles were reassayed to determine 99th percentile of GAD65Ab and IA-2Ab individually. Reanalyzing was done on fresh DBS punch outs. In children, born after 2001, with high individual GAD65Ab or IA-2Ab binding above the 99th percentile, a serum sample from the mother at delivery was also analyzed.
Insulin autoantibodies
Insulin autoantibodies were first screened in cord blood serum only with a recently described microassay with minor modifications. 29 Serum samples in duplicate wells were diluted (1:6 (7 ml serum þ 36 ml of Tris buffer/ 125 IÀinsulin)) in 96-well microtiter plates (96-well polystyrene non-tissue culture U-bottom plates, obtained from AB Göteborgs, Termometer fabrik, Sweden), containing also positive (low, medium and high binders) and negative reference samples on each plate. The plates were incubated for 72 h at 4 1C on a shaker (1296-003 Delfia Plateshake, PerkinElmer Life Sciences). Antibody-bound and free-labeled insulin were separated with 40% Protein A-Sepharose (Zymed, San Francisco, CA, USA) in a second set of precoated and washed microtiterplates which were incubated for 90 min at 4 1C on the shaker and the radioactivity counted in 1450 Microbeta scintillation counter (Wallac PerkinElmer, Upplands Väsby, Sweden). Results were expressed in arbitrary units and all samples above the 99th percentile were reanalyzed in duplicate wells with 8 U ml À1 cold insulin to identify serum samples with nonspecific binding. In the competing assay, the inter-and intra-assays coefficient of variations were 6.8 to 7.8% and 5.2 to 7.8%, respectively. The data are expressed in relative units based on the degree of blocking 125 I-insulin to the highest positive reference standard by cold insulin. Samples above the 99th percentile were considered to have high levels.
Study group
All mothers who reported diabetes (n ¼ 246), gestational diabetes (n ¼ 985) or unknown diabetes status (n ¼ 769) were excluded. Among newborns with a nondiabetic mother (n ¼ 33 683), GAD65-IA-2Ab were available for all but seven newborns. IAA analyzed in serum were available for 33 369 newborns. A total of 22 416 (66.5%) newborns had a parent returning the 2-month questionnaire. There was no difference in the prevalence of newborns with cord blood islet Abs between mothers who answered the questionnaire and the mothers who did not.
Statistical
Combined GAD65-IA-2Ab and IAA distributions were evaluated graphically for normality using quantile-quantile (Q-Q) normality plots. A Q-Q normality plot shows the quantiles of the autoantibodiy distribution (y axis) against the quantiles of a standard normal distribution (x axis). Prevalence of newborns with Abs across months and seasons were examined for differences using w 2 -tests. Pearson's correlation explored the relationship between log levels of GAD65Ab or IA-2Ab in newborns and mothers, and paired t-tests tested for mean differences between newborns and mothers. Prevalences of infections during pregnancy were calculated from mother's replies to the 2-month questionnaire. The standard errors of the prevalence were estimated using large sample normal approximation. Logistic regression examined for whether HLA-DQ2/8 and gestational infections were independently associated with prevalence of newborns with Abs after adjusting for age of mother and gender of the child.
Results
High levels (>99th percentile) of GAD65Ab and IA-2Ab in the combined assay ( Figure 1a) were found to represent 195 (0.6%) with GAD65Ab and 20 (0.1%) with IA-2Ab. Cord blood IAA serum levels above the 99th percentile (Figure 1b ) comprised of 336 (1.0%) newborns. A comparison of maternal antibody levels and levels in the cord blood showed a strong correlation both for GAD65Ab (r ¼ 0.96, P<0.001) (Figure 1c ) and IA-2Ab (r ¼ 0.90, P<0.001) (Figure 1d ). Islet Ab levels in the cord blood exceeded that in the mother (mean difference (95% CI)) for both GAD65Ab ( þ 0.31, (0.27 to 0.35) log U per ml; P<0.0001) and IA-2A ( þ 0.17 (0.05 to 0.28) log U per ml; P ¼ 0.007).
Monthly prevalence of newborns with islet Abs differed significantly (P<0.0001), with the highest prevalence seen in July, August and September and the lowest prevalence seen between January and April (Figure 2a) . In the third quarter of the year Figure 1 Quantiles of a standard normal distribution plotted against quantiles of (a) the combined analysis of glutamic acid decarboxylase (GAD65Ab) and islet-associated antigen 2 (IA-2Ab) (COMB GAD65-IA-2Ab) in U per ml, and (b) insulin autoantibodies (IAA) levels in relative units (RU). Quantiles of the standard normal distribution are presented on the horizontal axes as percentiles and the dashed vertical line indicates the 99th percentile. Islet autoantibody levels greater than the 99th percentile exceed those expected from a normal population. Cord blood islet autoantibody levels of (c) GAD65Ab and (d) IA-2Ab were correlated with the islet autoantibody levels of a mother. Fitted line indicates simple linear regression line.
(July, August, September), GAD65Ab (OR, 1.37; 95% CI, 1.01 to 1.85), IA-2Ab (OR, 2.09; 95% CI, 0.86 to 5.10) as well as IAA (OR, 2.02; 95% CI, 1.63 to 2.52) were all increased as compared to the rest of the year. Quarterly prevalence of newborns with cord blood islet Abs revealed that the unexpected seasonal variation (P<0.0001) was consistent in 4 years of screening (Figure 2b) .
We first tested the association between presence of cord blood islet Abs and the T1D high-risk HLA-DQ2/8 genotype in the newborn. As mothers were not HLA typed, only this genotype was informative for the mother being positive for either the DQ2 or the DQ8 susceptible haplotype. Cord blood islet Abs were associated with the HLA-DQ2/8 genotype (OR, 2.06; 95% CI, 1.47 to 2.88); P<0.0001). Individual cord blood islet Abs, GAD65Ab (OR, 1.95; 95% CI, 1.11 to 3.43; P ¼ 0.02), IA-2Ab (OR, 4.77; 95% CI, 1.40 to 16.26; P ¼ 0.01) and IAA (OR, 2.13; 95% CI, 1.40 to 3.25; P<0.0005) were also significantly associated with HLA-DQ2/8.
Among mothers reporting infections during pregnancy (n ¼ 4340), fever-related infections were reported by 1725 (39.8%), gastroenteritis-related infections by 806 (18.6%) and 671 (15.4%) mothers reported both. The proportion of mothers reporting gastroenteritis or fever peaked in November, December, January and February with low proportions from May to September (Figure 2c ). The different monthly patterns suggested that children born in the summer have more mothers reporting an infection in early pregnancy. Children born in the winter may have more mothers reporting an infection in late pregnancy. Overall neither reported gastroenteritis nor reported fever was associated with cord blood islet Abs.
Considering the consistent seasonal pattern observed over 4 years, we next examined by season of birth whether HLA-DQ2/8 or reported infections were associated with cord blood islet Abs. Newborns with the HLA-DQ2/8 genotype had an increased risk for cord blood islet Abs in the second (P ¼ 0.02), third (P ¼ 0.008) and fourth (P ¼ 0.007) quarters, but not in the first quarter (P ¼ 0.82) ( Table 1 ). In the third quarter, reported gastroenteritis was also associated with cord blood islet Abs (Table 1) .
In a multivariate logistic regression adjusting for maternal age and gender, an increased prevalence of newborns born with cord blood Abs in the third quarter was associated with reported gastroenteritis (OR, 1.80; 95% CI, 1.04 to 3.12; P ¼ 0.037) and also HLA-DQ2/8 genotype (OR, 2.97; 95% CI, 1.64 to 5.37; P ¼ 0.0003). 
Discussion
Our population-based study revealed that cord blood islet Abs showed a consistent seasonal variation over 4 years of screening. This major finding is of considerable interest as a seasonal variation is usually taken as an indication of exposure to nongenetic factors that may vary with the time of year. Indeed, the clinical onset of diabetes is consistently found to vary with the season. [37] [38] [39] Furthermore, the appearance of islet Abs in children followed from birth, because of their T1D high-risk HLA, also revealed a seasonal variation. 40 These authors speculate that the seasonal variation might be explained by the exposure of these children to virus. It is well accepted that islet Abs are markers for islet autoimmunity that eventually precipitate T1D. Hence, it is inferred that virus may trigger islet autoimmunity. To our knowledge a seasonal variation of cord blood islet Abs in children born to nondiabetic mothers has not previously been reported.
The fact, as confirmed in the present investigation, that cord blood islet Abs likely come from the mother further suggests that gestational nongenetic factors might have contributed to the development of islet Abs in the mother. Several studies in nondiabetic individuals either in population-based screening studies 41 or in families with T1D 40 have shown an association between HLA-DQ and islet Abs. Our study confirms that this association in the children born with the T1D high risk HLA-DQ2/8 genotype. Prior studies have suggested that the HLA-DQ2 haplotype is primarily associated with GAD65Ab and the HLA-DQ8 with IA-2Ab or IAA. 40, 41 If it would have been possible for us to follow the inheritance of either one of these haplotypes, it cannot be excluded that the association between HLA and the islet Abs developing in the mother would have been stronger.
The parents were not informed about islet Abs in the cord blood or about HLA risk of their child when information on gestational infections was obtained from questionnaires at 2 months of age. The infectious history showed most infectious events took place during the winter months which is consistent with viral epidemiological data affecting the general population during that part of the year. We focused on newborns born to nondiabetic mothers as it reduced the possibility of mothers having islet Abs well before pregnancy. A drawback to our analysis however was our inability to obtain blood samples at the beginning of or just before the pregnancy and rule out mothers who were islet Ab positive before pregnancy. Obtaining such samples would have represented an effort far beyond the resources of this study. Nevertheless, the consistent seasonal variation strongly suggests that some mothers might have different risks of recent development of islet Abs than other mothers. The observation that mothers who gave birth in the third quarter reported an increased frequency of gastroenteritis with or without fever during December, and the first 2 months of the year is consistent with the increased risk for T1D in children born to mothers with coxsackie or echo virus infections. We therefore speculate that T1D-HLA susceptible mothers exposed to, for example, virus infection during the winter months would subsequently develop islet Abs. These Abs were not detected until delivery but are likely to have developed just prior or during pregnancy.
We have previously shown that mothers reporting gastroenteritis or fever-related infections in several trimesters aggravates an association between the HLA-DQ2/8 genotype and birth weight. 34, 42 In the current study, we did not find any association between number of infections reported and prevalence of newborns with cord blood islet Abs; however, an association may still exist as we did not have information of maternal Abs at the start of pregnancy. We propose that development of islet autoimmunity during pregnancy of nondiabetic mothers may better reflect subclinical islet autoimmunity and may predict risk of mother or child developing T1D. In another recent study, we showed an association between cord blood Abs and fewer number of islet Abs at diagnosis in children of nondiabetic mothers. 43 It is planned therefore to also follow the nondiabetic mothers in the DiPiS study who gave birth to islet Ab positive children. Following T1D risk in children born with maternal islet Abs is part of the original DiPiS study design. 32 Cord blood islet Abs were determined through percentiles of our large cohort of 33 683 newborns and examined for outlying levels of islet Abs. The Q-Q normality plot (Figure 1 ) visually confirms our effective approach to analyze for children with binding levels above the normal range. The observed 1.6% newborns with high 'above normal' levels of islet Abs in the cord blood would seem a reasonable overall frequency of high binders. Other studies have reported frequencies of around 3%. 44 There was a lower number of high binders in 2001 (0.3%) as compared to the other years (0.6%) due to a downward drift in the GAD65Ab assay during the middle of 2001. However, this underestimation in 2001 likely reduced the significance of our results as a repeat of the analysis with the 2001 newborns omitted showed a stronger consistent seasonal quarterly trend in newborns with high GAD65Ab binding.
Our approach was to analyze the samples obtained from the mother either as DBS or serum in each child showing high islet Ab binding. As previously demonstrated for GAD65Ab and ICA, 31 levels of islet Abs in the offspring tended to be higher than in the serum sample obtained from the mother at the time of delivery. It is possible that the levels appear high in the offspring due to the hemodilution that takes place during pregnancy. Our data in this group of children born to nondiabetic mothers demonstrate a highly significant correlation in islet Ab levels between the child and the mother. We therefore conclude that in the majority of these children the islet Abs were of maternal origin.
The limitations of our study include single time point measure of islet Abs as compared to a persistent positivity, retrospective self-reporting of gestational infections, recall bias in how mothers replied to the questionnaire, no information on maternal IAA levels, and lack of maternal HLA-DQ allelic data to examine the full relationship of HLA on cord blood islet Abs. The recall bias, however, is likely to be largely nondifferential as parents were not informed about islet Abs in the cord blood or about HLA risk of their child. Despite the other limitations, an improvement in the quality and precision of maternal HLA and infectious history is likely to strengthen the association with seasonal prevalence of cord blood islet Abs. As seasonal variation in the diagnosis of T1D is well known, our study opens a new approach to dissect T1D pathogenesis since mothers' infections during pregnancy and HLA-associated development of islet Abs needs to be considered when following high-risk children.
